“Results Our findings indicated that the administration of STZ significantly increased the serum concentrations of glucose , triglycerides, cholesterol, CRP, IL-6, TNF-a, and MDA and decreased the serum levels of GSH and TAS (P<0.05) in diabetic rats.”